Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines

Leticia Monin(Centre Hospitalier Universitaire de Liège), Sheeba Irshad(King's College London), Clara Domingo‐Vila(King's College London), Sophie Papa(Guy's Hospital), Miguel Muñoz‐Ruiz(The Francis Crick Institute), Thanussuyah Alaguthurai(King's College London), Liane Dupont(University of Cambridge), Katie J. Doores(King's College London), Magdalene Joseph(King's College London), Anne Rigg(National Health Service), Jeffrey Seow(King's College London), Shraddha Kamdar(King's College London), James Spicer(King's College London), Jennifer Vidler(King's College Hospital), Piers Patten, Yin Wu(King's College London), Francesca Di Rosa(The Francis Crick Institute), Adam G. Laing(Xenetic Biosciences (United Kingdom)), Rosalind Graham(King's College London), Isaac Francos-Quijorna(Centro de Biología Molecular Severo Ochoa), Timothy Tree(King's College London), Carl Graham(King's College London), Helen Kakkassery(King's College London), Puay Lee(The Francis Crick Institute), Josephine Eum(King's College London), Irene del Molino del Barrio(King's College London), Mark Harries(Guy's and St Thomas' NHS Foundation Trust), Duncan R. McKenzie(The Francis Crick Institute), Elizabeth Harvey-Jones(Royal Marsden NHS Foundation Trust), Sultan Abdul-Jawad(King's College London), Thomas S. Hayday(King's College London), Adrian Hayday(The Francis Crick Institute), Muhammad Khan(Guy's and St Thomas' NHS Foundation Trust), Michael H. Malim(Office of Infectious Diseases), Sinha Shubhankar(King's College London), Ana Montes(Guy's and St Thomas' NHS Foundation Trust), Richard Davis(King's College London), Daniel Davies(Royal Free London NHS Foundation Trust), Jack Cooper(Guy's and St Thomas' NHS Foundation Trust), Paul Fields(St Thomas' Hospital), Maria Conde Poole(King's College London)
medRxiv
March 17, 2021
Cited by 61


Related Papers